Financial Insights, Inc. Johnson & Johnson Transaction History

Financial Insights, Inc.

$357 Million
Q2 2024

A detailed history of Financial Insights, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Financial Insights, Inc. holds 7,146 shares of JNJ stock, worth $1.1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

7,146

Previous 8,380 14.73%

Holding current value

$1.1 Million

Previous $1.33 Million 21.21%

% of portfolio

0.29%

Previous 0.38%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$144.38 - $157.78 $178,164 - $194,700	-1,234 Reduced 14.73%	7,146 $1.04 Million
Q1 2024 Apr 25, 2024	SELL	$155.22 - $162.74 $294,297 - $308,555	-1,896 Reduced 18.45%	8,380 $1.33 Million
Q4 2023 Jan 24, 2024	BUY	$145.6 - $158.88 $86,486 - $94,374	594 Added 6.14%	10,276 $1.61 Million
Q3 2023 Dec 06, 2023	BUY	$155.75 - $174.48 $89,089 - $99,802	572 Added 5.77%	10,483 $1.63 Million
Q2 2023 Jan 24, 2024	SELL	$154.35 - $166.11 $123,634 - $133,054	-801 Reduced 7.64%	9,682 $1.6 Million

Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $236,242 - $281,926	1,564 Added 18.74%	9,911 $1.54 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $366,537 - $411,359	2,288 Added 37.76%	8,347 $1.47 Million
Q3 2022 Oct 26, 2022	BUY	$161.33 - $179.52 $380,738 - $423,667	2,360 Added 63.8%	6,059 $990,000
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $3,700 - $4,092	-22 Reduced 0.59%	3,699 $657,000
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $25,460 - $28,913	-161 Reduced 4.15%	3,721 $659,000
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $10,603 - $11,764	-68 Reduced 1.72%	3,882 $664,000
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $10,336 - $11,486	-64 Reduced 1.59%	3,950 $638,000
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $10,844 - $11,632	-68 Reduced 1.67%	4,014 $6.61 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $10,408 - $11,592	-68 Reduced 1.64%	4,082 $671,000
Q4 2020 Feb 05, 2021	SELL	$137.11 - $157.38 $31,398 - $36,040	-229 Reduced 5.23%	4,150 $653,000
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $526,284 - $576,708	3,749 Added 595.08%	4,379 $652,000
Q2 2020 Aug 20, 2020	SELL	$128.81 - $155.51 $502,359 - $606,489	-3,900 Reduced 86.09%	630 $596,000
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $22,005 - $30,490	-198 Reduced 4.19%	4,530 $594,000
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $765 - $878	-6 Reduced 0.13%	4,728 $690,000
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $14,853 - $16,630	-117 Reduced 2.41%	4,734 $613,000
Q2 2019 Aug 20, 2019	BUY	$131.15 - $144.24 $32,656 - $35,915	249 Added 5.41%	4,851 $640,000
Q1 2019 May 23, 2019	BUY	$125.72 - $139.79 $45,007 - $50,044	358 Added 8.44%	4,602 $650,000
Q4 2018 Mar 08, 2019	BUY	$122.84 - $147.84 $521,332 - $627,432	4,244 New	4,244 $565,000

Others Institutions Holding JNJ

# of Institutions

4,143

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $403B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Insights, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Insights, Inc. with notifications on news.

Account

Financial Insights, Inc. Johnson & Johnson Transaction History